宁波大红鹰药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
169
NMPA:169
Drug Approvals
Olmesartan Medoxomil and Amlodipine Besylate Tablets
- Product Name
- 奥美沙坦酯氨氯地平片
- Approval Number
- 国药准字H20254109
- Approval Date
- May 13, 2025
NMPA
Dexamethasone Sodium Phosphate Injection
- Product Name
- 地塞米松磷酸钠注射液
- Approval Number
- 国药准字H33020981
- Approval Date
- Jun 12, 2020
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H33021099
- Approval Date
- Jun 12, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
Clinical Trials
No trials found
News
No news found